In sharp contrast to the notion that the loss of cell-cell junctional adhesion support the metastatic abilities of cancer cells, overexpression of claudins has been also linked to tumor progression, as in prostate cancer, where claudin-3 and -4 upregulation was consistently identified in clinically advanced tumors and positively correlated with disease recurrence (11). Here, CLDN3 is linked to neoplasm.